Abstract
DATE: |
November 12, 2009 |
TIME: |
1:15 - 3:00 pm |
LOCATION: |
Center for Clinical Sciences Research (CCSR), Rm 4205 |
TITLE: |
Estimating Life Years Added By Treatment |
SPEAKER: |
Mark A. Hlakty, MD |
To assess the cost-effectiveness of treatments, clinical effectiveness needs to be expressed as the number of life-years added by the new treatment in comparison with old treatment (or control). However, results of clinical trials are usually presented as survival probabilities or relative risk reductions. We have been investigating several methods for estimating life-years added based on individual patient data from clinical trials, particularly in assessing how this measure varies according to baseline characteristics of the patient. I will present our very preliminary results so far, and seek to discuss the best approaches to this problem.

